World Vaccine Congress Europe 2026 has ended. This guide stays up as the record of who was there. Next: WVC Europe 2027, Oct 25–27, 2027 in Lyon

CP

CHO Pharma at World Vaccine Congress Europe 2026

Oct 19–21, 2026 Amsterdam, Netherlands ~2k attendees Website

CHO Pharma takes part in 1 session at World Vaccine Congress Europe 2026 in Amsterdam, and exhibits. Its program centres on its K1/K2 glycoconjugate vaccine against hypervirulent, meaning especially aggressive, Klebsiella pneumoniae bacteria. It shares early safety results, and early data on whether the immune responses the vaccine triggers actually work, from its first trial in people.

OrganizationWorld Vaccine Congress Europe 2026 Attendance
CP
CHO Pharma
BiotechShowcase sponsor
Develops glycoconjugate vaccines, including a K1/K2 vaccine against hypervirulent Klebsiella pneumoniae in first-in-human trials.
Booth
Exhibiting (no floor booth listed)

Explore the full World Vaccine Congress Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Amsterdam. Leave your work email and we’ll be in touch.

Privacy

Download the full World Vaccine Congress Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at CHO Pharma

Tell us what you sell and we’ll find the people at CHO Pharma most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the World Vaccine Congress or its organizers. Submit a correction